Telix Pharmaceuticals Ltd Sustainability Reports
Telix Pharmaceuticals Limited is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. The company designs targeted radiation therapies and imaging agents primarily for prostate, kidney, and brain cancer applications.
Sector: Manufacturing
Country: Australia
Exchange: Australian Securities Exchange
LEI: 894500HTWOOGIHLLSB86
FIGI: BBG00HZHXWV5
9 reports from 2017 to 2024
- Telix Pharmaceuticals Ltd 2024 Sustainability Report
- Telix Pharmaceuticals Ltd 2023 Sustainability Report
- Telix Pharmaceuticals Ltd 2022 Environmental, Social, Governance and Sustainability (ESGS) Report
- Telix Pharmaceuticals Ltd 2021 Annual Report
- Telix Pharmaceuticals Ltd 2021 Environmental, Social and Governance (ESG) Report